Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling.
Although testosterone (T) has striking effects on mature skeletal size and structure, it is not clear whether this depends exclusively on adult circulating levels of T or whether additional early-life factors also play a role. We have compared the androgen-deficient hypogonadal (hpg) mutant mouse with intact, orchidectomized, and T-treated non-hpg mice to determine relative contributions of adult and perinatal T to bone growth and development. At 3 wk of age, although trabecular and cortical bone structure was normal, bone turnover was significantly altered in hpg male mice; osteoid volume (OV/BV) and osteoblast surface (ObS/BS) were significantly lower and osteoclast surface (OcS/BS) significantly higher in hpg mice compared with age-matched non-hpg mice, pointing to a role for the perinatal T surge in determining bone turnover levels before sexual maturity. At 9 wk of age, the hpg bone phenotype mimicked closely that of age-matched non-hpg mice that had been orchidectomized at 3 wk of age, including low trabecular bone mass and high bone turnover. These bone phenotypes of hpg and orchidectomized non-hpg mice were all prevented by replacement doses of T or dihydrotestosterone (DHT), suggesting that these are determined by adult sex steroid hormones. In contrast, a short bone phenotype that could not be prevented by T or DHT treatment was observed in 9-wk-old hpg mice yet not in intact or castrated non-hpg mice. These data suggest a role for the perinatal T surge in determining adult bone length and confirms that adult circulating T determines adult bone density.
Sims
Natalie A
NA
Department of Medicine at St. Vincent's Hospital, the University of Melbourne and St. Vincent's Institute, Fitzroy, Victoria, Australia. nsims@unimelb.edu.au
Brennan
Karen
K
Spaliviero
Jenny
J
Handelsman
David J
DJ
Seibel
Markus J
MJ
D000728:Androgens / Q000172:deficiency*; D000818:Animals; D015519:Bone Density / Q000502:physiology; D001846:Bone Development / Q000187:drug effects / Q000502:physiology*; D016723:Bone Remodeling / Q000502:physiology*; D001842:Bone and Bones / Q000378:metabolism*; D013196:Dihydrotestosterone / Q000494:pharmacology; D005269:Femur / Q000033:anatomy & histology / Q000378:metabolism; D007006:Hypogonadism / Q000378:metabolism; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008817:Mice, Mutant Strains; D009919:Orchiectomy; D015675:Osteocalcin / Q000097:blood; D013739:Testosterone / Q000378:metabolism* / Q000494:pharmacology; D013977:Tibia / Q000033:anatomy & histology / Q000378:metabolism
D000728:Androgens; D013196:Dihydrotestosterone; D015675:Osteocalcin; D013739:Testosterone